The Canadian Press reports that Canada is ready to cave to European demands for changes to patent rules that could cost Canadians hundreds of millions of dollars in higher health care costs. The ministerial meeting on the remaining CETA issues is set for next week.
Canada Reportedly Ready to Cave on CETA Drug Patent Demands
November 14, 2012
Share this post
One Comment

Law Bytes
Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
byMichael Geist

Ep. 265 – Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
April 20, 2026
Michael Geist
March 30, 2026
Michael Geist
March 16, 2026
Michael Geist
Search Results placeholder
Michael Geist on Substack
Recent Posts
Addressing the AI Policy Challenge: My Appearance before the Standing Senate Committee on Transport and Communications
Lawful Access Heads to Committee: The Opposition Found Its Voice, the Government Never Found Its Defence
Is Data De-Identification Dead?: Why the AI Privacy Risk Isn’t What It Learns, But What It Figures Out
The Law Bytes Podcast, Episode 265: Jason Millar on Claude Mythos, Project Glasswing, and the Governance Crisis in Frontier AI
A Standard That Doesn’t Exist: Parliamentary Secretary for Justice Offers Misleading Defence of Bill C-22’s Lower Threshold for Subscriber Information

Canada — The Real Home Surrender Monkeys
Other countries must love to negotiate with us — We seem to cave to anyone and everyone. Is there anyone with a back bone in this country? Anyone?